—

Remedium Capital Partners, LLC

Q1 2026 13F Holdings

  • Location
    fort lauderdale, FL
  • Num holdings

    6

  • Value ($000)

    $281,150

  • Date Filed
    05/19/2026
  • Form type
    restatement
  • CIK
    0002104501
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

Oruka Therapeutics Inc

COM
687604108
$76.8M
27 %

1,565,661

S
SYRE

Spyre Therapeutics Inc

COM
00773J202
$73.45M
26 %

1,456,231

---

Damora Therapeutics Inc

COM
36322Q206
$52.98M
19 %

2,045,473

A
APGE

Apogee Therapeutics Inc

COM
03770N101
$49.12M
18 %

583,591

---

Jade Biosciences Inc

COM
008064206
$22.17M
8 %

1,577,750

---

Crescent Biopharma Inc

COM
38000Q201
$6.64M
2 %

361,250

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6